0001609251-23-000001.txt : 20230215 0001609251-23-000001.hdr.sgml : 20230215 20230215080911 ACCESSION NUMBER: 0001609251-23-000001 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 EFFECTIVENESS DATE: 20230215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 23633675 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001609251 XXXXXXXX 12-31-2022 12-31-2022 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 /s/ Paul J. Paolino New York NY 02-14-2023 0 12 323644 false INFORMATION TABLE 2 krensavage13f12312022.xml KRENSAVAGE 13F 12.31.2023 ALKERMES PLC COM G01767105 36629 1401783 SH SOLE 1401783 0 0 BIOGEN INC COM 09062X103 49016 177004 SH SOLE 177004 0 0 CARDINAL HEALTH INC COM 14149Y108 25578 332749 SH SOLE 332749 0 0 EAGLE PHARMACEUTICALS INC COM 269796108 3356 114825 SH SOLE 114825 0 0 EMBECTA CORP COM 29082K105 25737 1017657 SH SOLE 1017657 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 27671 594818 SH SOLE 594818 0 0 EXELIXIS INC COM 30161Q104 34294 2138039 SH SOLE 2138039 0 0 KODIAK SCIENCES INC COM 50015M109 3319 463598 SH SOLE 463598 0 0 REGENERON PHARMACEUTICALS COM 75886F107 43364 60103 SH SOLE 60103 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 18721 644664 SH SOLE 644664 0 0 UNITED THERAPEUTICS CORP COM 91307C102 53407 192048 SH SOLE 192048 0 0 VANDA PHARMACEUTICALS INC COM 921659108 2552 345290 SH SOLE 345290 0 0